Brand Engagement Network Completes Deal for Exclusive AI Engagement Solution

Brand Engagement Network Inc. (Nasdaq: BNAI), a company specializing in providing safe and secure generative AI for businesses and their consumers, recently disclosed the finalization of a Vendor Services Project Agreement. This agreement was made with a prominent global advertising and communications agency, which is part of a top advertising holding company globally. The purpose of this collaboration is to develop a custom AI engagement communication method for one of the top 10 global pharmaceutical clients, focusing on an established prescription pharmaceutical drug. The specific names of the pharmaceutical company and the advertising agency remain undisclosed until an official release of the AI solution.

As outlined in the agreement, Brand Engagement Network (BEN) is set to rake in $250,000 in revenue for development services detailed in two Statements of Work during Q4′ 2025. Additionally, the Company is expecting monthly recurring license fees, not associated with the development work, to commence in the first quarter of 2026. This collaborative effort is anticipated to be a significant boon to BEN’s Q4 2025 results, combined with its singular Latin American licensing partnership and an upcoming project to launch Skye Salud, an AI healthcare platform designed for Mexico. These initiatives underscore the increasing acceptance of BEN’s secure AI technology in the healthcare domain across the United States and Mexico.

Tyler Luck, who currently holds the position of Acting Chief Executive Officer at BEN, expressed his thoughts on the recent agreement. He emphasized the significance of BEN’s technological advancements in the healthcare sector, delivering secure, reliable, and efficient AI solutions for pharmaceutical manufacturers, healthcare providers, and patients alike. Luck asserted the company’s commitment to creating consumer experiences that prioritize accuracy, reliability, and integrity.

For further information regarding the specifics of the agreement and settlement, interested parties are advised to refer to the Company’s Current Report on Form 8-K, submitted to the Securities and Exchange Commission on December 29, 2025. Likewise, additional background information about BEN’s healthcare initiatives in Latin America, including the Skye Salud platform developed for Mexico, can be found on the Company’s investor relations website.

Brand Engagement Network (BEN) is a pioneer in conversational AI technology, boasting human-like AI avatars, and is headquartered in Jackson, WY. BEN specializes in delivering highly personalized, multi-modal AI engagement encompassing text, voice, and vision interactions. The company targets industries with substantial workforce gaps and a scope for transforming consumer engagement with networks, providers, and brands. BEN’s success is underlined by its diverse portfolio of conversational AI applications, which offer enhanced customer experience, elevated automation, and improved operational efficiencies. BEN aspires to collaborate with companies possessing complementary capabilities and networks to yield substantial business outcomes.

This press release includes forward-looking statements, in accordance with Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements outline the company’s expectations regarding future financial performance, strategic direction, operations, financial standing, revenue estimates, and projected outcomes. The company’s intent with such statements is to identify future prospects and plans for holistic growth and development.